Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Revolution Medicines (RVMD) Deferred Taxes (2020 - 2024)

Revolution Medicines (RVMD) has 4 years of Deferred Taxes data on record, last reported at $762000.0 in Q4 2024.

  • For Q4 2024, Deferred Taxes rose 1672.09% year-over-year to $762000.0; the TTM value through Dec 2024 reached $928000.0, up 580.83%, while the annual FY2024 figure was $762000.0, 80.51% down from the prior year.
  • Deferred Taxes reached $762000.0 in Q4 2024 per RVMD's latest filing, up from $43000.0 in the prior quarter.
  • Across five years, Deferred Taxes topped out at $762000.0 in Q4 2024 and bottomed at -$359000.0 in Q4 2020.
  • Average Deferred Taxes over 4 years is $217166.7, with a median of $83000.0 recorded in 2022.
  • Peak YoY movement for Deferred Taxes: tumbled 65.04% in 2023, then surged 1672.09% in 2024.
  • A 4-year view of Deferred Taxes shows it stood at -$359000.0 in 2020, then surged by 134.26% to $123000.0 in 2022, then crashed by 65.04% to $43000.0 in 2023, then soared by 1672.09% to $762000.0 in 2024.
  • Per Business Quant database, its latest 3 readings for Deferred Taxes were $762000.0 in Q4 2024, $43000.0 in Q4 2023, and $123000.0 in Q4 2022.